IBM, Nuance to apply 'Watson' analytics to healthcare

We've seen the ease with which he bested his human opponents on the Jeopardy! challenge. Next up for Watson the supercomputer? Improving the delivery of healthcare.

IBM and Nuance Communications announced Thursday a research agreement to explore, develop and commercialize the Watson computing system’s advanced analytics capabilities in the healthcare industry.

The research and technology initiative will combine IBM’s Deep Question Answering (QA), Natural Language Processing, and Machine Learning capabilities with Nuance’s speech recognition and Clinical Language Understanding (CLU) solutions for the diagnosis and treatment of patients that provide hospitals, physicians and payers access to critical and timely information.

The two companies expect the first commercial offerings from the collaboration to be available in 18-24 months.

[See also:Nuance and IBM collaborate on clinical language understanding.]

Big Data and Healthcare Analytics Forum June 4-5 Washington

Additionally, Columbia University Medical Center and the University of Maryland School of Medicine will contribute their medical expertise and research to the collaborative effort. For example, physicians at Columbia University are helping identify critical issues in the practice of medicine where the Watson technology may be able to contribute, and physicians at the University of Maryland are working to identify the best way that a technology like Watson could interact with medical practitioners to provide the maximum assistance.

Watson’s ability to analyze the meaning and context of human language, quickly processing information to find precise answers can assist decision makers, such as physicians and nurses, unlock important knowledge and facts buried within huge volumes of information, and offer answers they may not have considered to help validate their own ideas or hypotheses.

“Combining our analytics expertise with the experience and technology of Nuance, we can transform the way that healthcare professionals accomplish everyday tasks by enabling them to work smarter and more efficiently” said John E. Kelly III, MD, senior vice president and director of IBM Research. “This initiative demonstrates how we plan to apply Watson’s capabilities into new areas, such as healthcare with Nuance.”

For example, a doctor considering a patient’s diagnosis could use Watson’s analytics technology, in conjunction with Nuance’s voice and clinical language understanding solutions, to rapidly consider all the related texts, reference materials, prior cases, and latest knowledge in journals and medical literature to gain evidence from many more potential sources than previously possible, thereby helping the medical professional to confidently determine the most likely diagnosis and treatment options.

Previous
1

Showing 3 Comments

granmx2 say: Technology is exciting

The synergies between these companies and the commercialized product that will emerge out of this relationship could potentially change the healthcare landscape as we know it. I think Nuance definitely made the right decision in partnering with IBM on these development efforts. It was obvious the Nuance lacked expertise with NLP and I'm glad to see that it will now be apart of their technology offerings!

RMartinMD say: IBM Changes Mind about Healthcare, Sticking to TV Competitions

Leveraging Watson’s amazing powers to advance healthcare would save lives and undoubtedly make the world a better place. But my understanding is that IBM’s leaders have had a change of heart after experiencing the thrill of dominating human opponents by being a contestant on a TV show. So they’ve decided to focus all of their attention training Watson to become the next American Idol. Full story at http://informatimusicology.blogspot.com.

Ceusters say: I must have been doing something right...

Well, I now understand what it means to come too early in the market. I started my CLU research in the early nineties, founded L&C in 1998 to commercialize and further develop the technology. I left L&C in 2005; last year it was bought by Nuance, contributing now to the efforts announced here, as well as in yesterday's announcement concerning the collaboration with 3M. I remember lively the days when I was sitting in the corporate offices of 3M, Oracle, L&H (who once bought what is now Nuance), IBM, etc trying to work out collaborations, but we were obviously too small and not convincing enough. Nevertheless, I am quite happy reading news of this sort: I might have been a bad entrepreneur, but I am clearly not too bad a researcher and scholar.

Werner Ceusters
Director Ontology Research Group
University at Buffalo